MedPage Today November 13, 2024
Katherine Kahn

— Pre-vaccine era data suggest underrecognized burden of disease, especially in older adults

In the years before the introduction of respiratory syncytial virus (RSV) vaccines, the virus was linked with substantial hospitalizations, intensive care unit (ICU) admissions, and in-hospital deaths among adults, according to a cross-sectional analysis of CDC data.

Adjusted analysis showed estimated RSV-associated hospitalization rates ranging from 48.9 per 100,000 adults during the 2016-2017 respiratory season to 76.2 per 100,000 in 2017-2018, reported researchers led by Fiona Havers, MD, MHS, of CDC’s National Center for Immunizations and Respiratory Diseases in Atlanta.

Estimated hospitalization rates were highest among adults ages 75 and older, ranging from 244.7 per 100,000 in 2022-2023 to 411.4 per 100,000 in 2017-2018, findings in JAMA...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
Related Articles:
Mpox Clade I in the U.S. Should Be a Wake-Up Call
Journalists Address HHS Under Trump, Rural PFAS Contamination, and Bird Flu
Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.
It's sick season. Here's how to protect yourself from norovirus, COVID-19, flu and RSV
China marks muted 5th anniversary of first COVID death

Share This Article